4//SEC Filing
McCamish Mark Anthony 4
Accession 0001179110-20-009709
CIK 0001012477other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 7:17 AM ET
Size
14.4 KB
Accession
0001179110-20-009709
Insider Transaction Report
Form 4
McCamish Mark Anthony
Director
Transactions
- Award
Stock Option (right to buy)
2020-09-13+50,000→ 50,000 totalExercise: $5.30Exp: 2030-09-13→ ADSs (50,000 underlying)
Footnotes (2)
- [F1]The stock options shall vest and become exercisable in the following manner: 33% on September 13, 2021; 33% on September 13, 2022; and the remaining 34% on September 13, 2023.
- [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001390798
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 7:17 AM ET
- Size
- 14.4 KB